Cause-specific mortality in patients with head and neck cancer: Long-term follow-up of a population-based cohort from 1986 to 2012 accounting for competing risks

Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with approximately 630,000 annual cases diagnosed worldwide [1]. Despite the declining prevalence of smoking, the incidence of HNSCC is increasing [2], although the 5-year relative survival rate has improved somewhat through a changing etiology coupled with a rise in human papillomavirus (HPV)-associated disease and advances in treatment [3,4].

Source: Oral Oncology - February 20, 2018 Category: Cancer & Oncology Authors: Janne A. V äisänen, Olli-Pekka Alho, Petri T. Koivunen, Esa Läärä Source Type: research